Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Stryker earns FDA clearance for new bone and soft tissue removal platform

15 October 2026 · By · Wire by Fusion42

Published

15 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 15 October 2026 · Fusion42 review

Stryker received FDA 510(k) clearance for Sonopet 3, an enhanced ultrasonic bone and soft tissue removal platform featuring pulse control and integrated surgical workflow technology. The company plans clinical cases starting this month and a full commercial launch later in the fall.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Stryker's FDA clearance for Sonopet 3 opens immediate US market access for ultrasonic surgical tools with enhanced control, putting pressure on competitors to match integration and ergonomics or lose clinical relevance.

◆ Coverage

1 source · 15 Oct 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemedical-devicesurgical-technologybone-tissue-removalstryker